📰 Mark Mcclellan News
Page 38 - Mark Mcclellan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Mcclellan. Real-time updates on events, politics, business and more.
January 25, 2021
3 reasons West Virginias COVID-19 vaccination effort is working so well West Virginia is doing better than probably any other state in vaccinating its population against COVID-19. About 9 percent of West Virginians have already gotten their first dose, better than any state but Alaska, and West Virginia is No. 1 in giving out second doses, The New York Times reports. West Virginia has used 83 percent of the doses allocated to the state, by far the highest percentage. Part of West Virginias suc...
January 25, 2021
Heres why West Virginia is a leader in the U.S. vaccine rollout. Members of a vaccine task force met this month in West Virginia’s command center in Charleston.Credit...Kristian Thacker for The New York Times Published Jan. 25, 2021Updated Feb. 8, 2021 Carolyn Zain had heard horror stories about the nation’s coronavirus vaccine rollout: long waits, clunky websites, people being turned away. So when her health department announced it was expanding appointments, she armed herself with two pho...
January 25, 2021
Share Source: AP Photo/Alex Brandon As CNN breathlessly ran with the bogus "scoop" that the Biden administration had been left with no vaccine distribution plan, forcing the new presidents team to "start from scratch," the narrative began disintegrating almost instantly. It was patently untrue, as should have been obvious to literally anyone paying even the slightest bit of attention to actual events. Dr. Anthony Fauci, who was borderline worshiped by many on the Left during the Trump admin...
January 25, 2021
Official site of The Week Magazine, offering commentary and analysis of the days breaking news and current events as well as arts, entertainment, people and gossip, and political cartoons.
January 23, 2021
CDC reports record number of daily Covid-19 vaccinations as states struggle with supply CNN 1/23/2021 By Theresa Waldrop, Madeline Holcombe and Jason Hanna, CNN © Harrison Hill/USA TODAY/Sipa USA Jan 7, 2021; Mission Hill, CA, USA; Ararat House registered nurse Arpa Davoudian prepares to administer a COVID-19 vaccine to a resident at the Ararat House Nursing Facility on Jan. 7, 2021.. Mandatory Credit: Harrison Hill-USA TODAY/Sipa USA The US Centers for Disease Control and ...
January 23, 2021
Dr. Mark McClellan, a former Food and Drug Administration commissioner, told CNBC that Johnson & Johnson is "going all out with its production."
January 22, 2021
As the Biden administration takes power with a pledge to tame the most dire public health crisis in a century, one pillar of its strategy is to significantly increase the supply of Covid-19 vaccines. But federal health officials and corporate executives agree that it will be impossible to increase the immediate supply of vaccines before April because of lack of manufacturing
January 22, 2021
The US ‘can and should’ vaccinate up to 85% of adults by the end of summer, Fauci says Despite challenges with the distribution and administration of Covid-19 vaccines, the US “can and should” vaccinate 70-85% of US adults by the end of summer, infectious disease expert Anthony Fauci said Thursday. If officials do hit that benchmark, it could means a semblance of normalcy by the fall, the director of the National Institute of Allergy and Infectious Diseases said. “When you put …. th...
January 22, 2021
COVID-19 Hospitalizations In US Declining In Most States WASHINGTON (dpa-AFX) - COVID-19 Hospitalizations in the U.S. declined in almost every state over the past week, COVID Tracking Project said on Thursday. Only New York saw an increase in hospitalized patients, the U.S. collaborative volunteer-run effort to track the pandemic said on Twitter. After 16 weeks of increases, weekly hospitalizations are down 4 percent. The countrys COVID hospitalization numbers are continuing to fall on a daily ...
January 22, 2021
Johnson & Johnson board member Dr. Mark McClellan told CNBC that “if the clinical trial works out,” the company could significantly increase the nation’s